Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hypoxia × Oxygen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 3 Solitary Pulmonary Nodule 2 Paresthesia 2 Neoplasms 2 Multiple Pulmonary Nodules 2 Hypesthesia 2 Depression 2 Anxiety Disorders 2 Surgical Wound Infection 1 Skin Neoplasms 1 Radiation Injuries 1 Pulmonary Atelectasis 1 Postoperative Complications 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia 1 Hypoxia 1 Hematologic Neoplasms 1 Dyspnea 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

TH 302 4 3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 4 pimonidazole 3 Propofol 3 Injections 3 fluoroazomycin arabinoside 2 Radiotherapy 2 pomalidomide 1 fluoromisonidazole 1 fludarabine 1 Tirapazamine 1 Temozolomide 1 Sodium Chloride 1 Sevoflurane 1 Saline Solution 1 Oxygen 1 Nitroglycerin 1 Nimorazole 1 Magnetic Resonance Spectroscopy 1 Ketamine 1 Ipilimumab 1 Hydroxychloroquine 1 Furosemide 1 Ferrosoferric Oxide 1 Exercise 1 Ethiodized Oil 1 Diagnostic Imaging 1 Dexmedetomidine 1 Dexamethasone 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04566419 2022-09-16

SAMURAI

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Completed

Hypoxia, Pulmonary Atelectasis, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡